Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy

International Journal of Hyperthermia

Volumn 27, Issue 7, 2011, Pages 663-671

  Krupka, Tianyi M ^a   Exner, Agata A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal adenocarcinoma; Hyperthermia therapy; Pluronic triblock copolymer; Radiofrequency ablation; Thermosensitiser

Indexed keywords

ETHYLENE OXIDE; POLOXAMER; PROPYLENE OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER THERAPY; CARCINOMA CELL; CHEMICAL STRUCTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HEAT SENSITIVITY; HYDROPHILICITY; HYPERTHERMIC THERAPY; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; RAT; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CATHETER ABLATION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPERTHERMIA, INDUCED; MALE; MOLECULAR WEIGHT; POLOXAMER; RATS;

EID: 80054086673     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2011.599828     Document Type: Article

References (39)

1. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA Rapoport NY. Drug delivery in Pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release 2002;84:39-47. (Pubitemid 35223412)
2. Husseini GA, Runyan CM, Pitt WG. Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles. BMC Cancer 2002;2(20), doi: 10.1186/ 1471-2407-2-20.
3. Husseini GA, Christensen DA, Rapoport NY, Pitt WG. Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide. J Control Release 2002;83:303-305. (Pubitemid 35282472)
4. Katz DH, Marcelletti JF, Khalil MH, Pope LE, Katz LR. Antiviral activity of 1-docosanol, an inhibitor of lipidenveloped viruses including herpes simplex. Proc Natl Acad Sci USA 1991;88:10825-10829. (Pubitemid 21915931)
5. Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, Exner AA. Formulation and characterization of echogenic lipid-Pluronic nanobubbles. Mol Pharm 2010;7:49-59.
6. Lai JI, Shafi KV, Ulman A, Loos K, Lee Y, Vogt T, Lee W, Ong NP. Controlling the size of magnetic nanoparticles using Pluronic block copolymer surfactants. J Phys Chem B 2005;109:15-18. (Pubitemid 40120936)
7. Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV. Differential metabolic responses to Pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers. J Control Release 2010;142:89-100.
8. Exner AA, Krupka TM, Scherrer K, Teets JM. Enhancement of carboplatin toxicity by Pluronic block copolymers. J Control Release 2005;106:188-197. (Pubitemid 41140094)
9. Batrakova EV, Li S, Alakhov VY, Elmquist WF, Miller DW, Kabanov AV. Sensitization of cells overexpressing multidrugresistant proteins by Pluronic P85. Pharm Res 2003;20:1581-1590. (Pubitemid 37268272)
10. Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 2003;91:75-83. (Pubitemid 37288878)
11. Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV. Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther 2003;304:845-854. (Pubitemid 36152365)
12. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002;54:759-779. (Pubitemid 35247525)
13. Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer 2001;85:1987-1997. (Pubitemid 34775338)
14. Miller DW, Batrakova EV, Kabanov AV. Inhibition of multidrug resistance-associated protein (MRP) functional activity with Pluronic block copolymers. Pharm Res 1999;16:396-401. (Pubitemid 29162097)
15. Alakhov V, Moskaleva E, Batrakova EV, Kabanov AV. Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjug Chem 1996;7:209-216.
16. Krupka TM, Weinberg BD, Wu H, Ziats NP, Exner AA. Effect of intratumoral injection of carboplatin combined with Pluronic P85 or L61 on experimental colorectal carcinoma in rats. Exp Biol Med (Maywood) 2007;232:950-957. (Pubitemid 47026802)
17. Weinberg BD, Krupka TM, Haaga JR, Exner AA. Combination of sensitizing pretreatment and radiofrequency tumor ablation: Evaluation in rat model. Radiology 2008;246:796-803.
18. Solbiati L, Livraghi T, Goldberg SN, Lerace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001;221:159-166. (Pubitemid 32880383)
19. Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: Physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001;48:359-367. (Pubitemid 32391567)
20. Flanders VL, Gervais DA. Ablation of liver metastases: Current status. J Vasc Interv Radiol 2010;21:S214-222.
21. Zytoon AA, Ishii H, Murakami K, El-kholy MR, Furuse J, El- Dorry A, El-Malah A. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 2007;37:658-672. (Pubitemid 47617785)
22. McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, Kee ST. Percutaneous ablation of hepatocellular carcinoma: Current status. J Vasc Interv Radiol 2010;21:S204-213.
23. Bruners P, Lipka J, Gunther RW, Schmitz-Rode T, Mahnken AH. Bipolar radiofrequency ablation: Is the shape of the coagulation volume different in comparison to monopolar RF-ablation using variable active tip lengths? Minim Invasive Ther Allied Technol 2008;17:267-274.
24. Hong K, Georgiades C. Radiofrequency ablation: Mechanism of action and devices. J Vasc Interv Radiol 2010;21:S179-186.
25. Wu H, Exner AA, Krupka TM, Weinberg BD, Haaga JR. Vasomodulation of tumor blood flow: Effect on perfusion and thermal ablation size. Ann Biomed Eng 2009;37:552-564.
26. Krupka TM, Dremann D, Exner AA. Time and dose dependence of Pluronic bioactivity in hyperthermia-induced tumor cell death. Exp Biol Med (Maywood) 2009;234:95-104.
27. Griffin WC. Classification of surface-active agents by 'HLB'. J Soc Cosmet Chem 1949;1:311-326.
28. Nelson JL, Roeder BL, Carmen JC, RoloH F, Pitt WG. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res 2002;62:7280-7283. (Pubitemid 36025250)
29. Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF, Kabanov AV. Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release 2004;100:389-397. (Pubitemid 39572919)
30. Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol 1986;31:229-234. (Pubitemid 16104025)
31. Wei LJLDY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-1073.
32. Lin DY. MULCOX: A computer program for the Cox regression analysis of multiple failure time variables. Comput Methods Programs Biomed 1990;32:125-135. (Pubitemid 20230347)
33. Bewick V, Cheek L, Ball J. Statistics review 12: Survival analysis. Crit Care 2004;8:389-394. (Pubitemid 39468062)
34. Danson S, Ferry D, Alakhov V, Margison J, Kerr D, Jowle D, Brampton M, Halbert G, Ranson M. Phase I dose escalation and pharmacokinetic study of Pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004;90:2085-2091. (Pubitemid 38869710)
35. Koolman J, Roehm KH. Color Atlas of Biochemistry. New York, Stuttgart: Thieme; 2005.
36. Dynlacht JR, Fox MH. The effect of 45°C hyperthermia on the membrane fluidity of cells of several lines. Radiat Res 1992;130:55-60.
37. Konings AW, Ruifrok AC. Role of membrane lipids and membrane fluidity in thermosensitivity and thermotolerance of mammalian cells. Radiat Res 1985;102:86-98. (Pubitemid 15112263)
38. Kabanov AV. Micelles of amphilphilic block copolymers as vehicles for drug delivery. Masterdam: Elsevier; 2000. pp 347-376.
39. Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999;16:1373-1379. (Pubitemid 29449373)